DCM
CEMI

Delpha Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Delpha Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-232
Closed -$2K – 1711
2017
Q4 		$2K Buy
+232
New +$1.57K ﹤0.01% 1545

Other funds holding CEMI

ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return

Delpha Capital Management's CEMI Position: Q1 2018 in Review

Delpha Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2018, closing a stake of 232 shares — an estimated $2K sold.

Delpha Capital Management first reported a position in CEMI in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 27 funds tracked by Wall St. Rank hold CEMI as of Q1 2018.

  • Delpha Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 232 Chembio diagnostics, Inc. shares in Q1 2018, an estimated $2K.
  • Delpha Capital Management first reported a position in Chembio diagnostics, Inc. in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Chembio diagnostics, Inc. position peaked at $2K in Q4 2017.
  • 27 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.